133 related articles for article (PubMed ID: 37832865)
1. Nodular type but not vitamin D levels increases the risk of second primary cancers in melanoma patients: An observational study of 663 patients.
Massa A; Isasi-Fuster A; Requena C; Manrique-Silva E; Kumar R; Nagore E
Actas Dermosifiliogr; 2024 Feb; 115(2):143-149. PubMed ID: 37832865
[TBL] [Abstract][Full Text] [Related]
2. Nodular Type but Not Vitamin D Levels Increases the Risk of Second Primary Cancers in Melanoma Patients: An Observational Study of 663 Patients.
Massa A; Isasi-Fuster A; Requena C; Manrique-Silva E; Kumar R; Nagore E
Actas Dermosifiliogr; 2024 Feb; 115(2):T143-T149. PubMed ID: 38048949
[TBL] [Abstract][Full Text] [Related]
3. Types of second primary cancer influence overall survival in cutaneous melanoma.
Zheng G; Chattopadhyay S; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
BMC Cancer; 2021 Oct; 21(1):1123. PubMed ID: 34663263
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma.
Timerman D; McEnery-Stonelake M; Joyce CJ; Nambudiri VE; Hodi FS; Claus EB; Ibrahim N; Lin JY
Oncotarget; 2017 Jan; 8(4):6873-6882. PubMed ID: 28036288
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
Espinosa P; Pfeiffer RM; García-Casado Z; Requena C; Landi MT; Kumar R; Nagore E
Eur J Cancer; 2016 Jan; 53():115-24. PubMed ID: 26702765
[TBL] [Abstract][Full Text] [Related]
8. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Vitamin D Serum Levels in Cutaneous Melanoma.
Moro R; Sánchez-Silva A; Aguerralde-Martin M; González-Cuevas R; Peruilh-Bagolini L; Traves V; Manrique-Silva E; Requena C; Nagore E
Actas Dermosifiliogr; 2022 Apr; 113(4):347-353. PubMed ID: 35623724
[TBL] [Abstract][Full Text] [Related]
10. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
11. Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures.
Hardie CM; Elliott F; Chan M; Rogers Z; Bishop DT; Newton-Bishop JA
J Invest Dermatol; 2020 Feb; 140(2):327-337.e2. PubMed ID: 31425707
[TBL] [Abstract][Full Text] [Related]
12. [Vitamin D and the skin].
Libon F; Cavalier E; Nikkels AF
Rev Med Liege; 2013 Sep; 68(9):458-64. PubMed ID: 24180201
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor and CD86 expression in the skin of vitamin D-deficient swine.
Trowbridge RM; Mitkov MV; Hunter WJ; Agrawal DK
Exp Mol Pathol; 2014 Feb; 96(1):42-7. PubMed ID: 24239751
[TBL] [Abstract][Full Text] [Related]
14. Association between multiple cutaneous melanoma and other primary neoplasms.
Manganoni AM; Pavoni L; Farisoglio C; Sereni E; Chiudinelli M; Calzavara-Pinton P
Clin Exp Dermatol; 2012 Dec; 37(8):857-61. PubMed ID: 23020153
[TBL] [Abstract][Full Text] [Related]
15. High serum vitamin D level correlates with better prognostic indicators in primary melanoma: A pilot study.
Lim A; Shayan R; Varigos G
Australas J Dermatol; 2018 Aug; 59(3):182-187. PubMed ID: 28332194
[TBL] [Abstract][Full Text] [Related]
16. Sunlight, vitamin D and malignant melanoma: an update.
Reichrath J; Reichrath S
Adv Exp Med Biol; 2014; 810():390-405. PubMed ID: 25207378
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D insufficiency and serum levels related to the incidence and stage of cutaneous melanoma: a systematic review and meta-analysis.
Shellenberger RA; Gowda S; Kurn H; Albright J; Mayo MH
Melanoma Res; 2023 Aug; 33(4):265-274. PubMed ID: 37199748
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.
Wyatt C; Lucas RM; Hurst C; Kimlin MG
PLoS One; 2015; 10(5):e0126394. PubMed ID: 25970336
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.
Paolino G; Moliterni E; Didona D; Garelli V; Corsetti P; Lopez T; Richetta AG; Cantisani C; Bottoni U; Calvieri S
Med Oncol; 2015 Jan; 32(1):451. PubMed ID: 25516505
[TBL] [Abstract][Full Text] [Related]
20. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
